申请人:GARGAMEL (ZHUHAI) BIOTECH LTD.
公开号:US20220106319A1
公开(公告)日:2022-04-07
The present invention provides a compound represented by a general formula I and a pharmaceutically acceptable salt, stereisomer, ester, prodrug, metabolite, solvate, or deuterated compound thereof. The compound is a JAK inhibitor and can prevent and/or treat an inflammatory disease or cancer in humans and/or animals.